RAFAEL HOLDINGS, INC. Operating Cash Flow
RAFAEL HOLDINGS, INC. (RFL) reported Operating Cash Flow of -$21.61 million for the 9-month period ending 2026-04-30, per its 10-Q filed 2026-06-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-06-11
- RAFAEL HOLDINGS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-04-30 was -$7.28M.
- RAFAEL HOLDINGS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-01-31 was -$7.52M.
- RAFAEL HOLDINGS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-10-31 was -$6.81M.
- RAFAEL HOLDINGS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-07-31 was -$10.38M.
- RAFAEL HOLDINGS, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$18.92M.
- RAFAEL HOLDINGS, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$7.80M.
- RAFAEL HOLDINGS, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$10.89M.
- RAFAEL HOLDINGS, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$26.08M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|
| 2026-04-30 | -$7.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-06-11 | -$14.81M derived: sum of 2 quarters · filed 2026-06-11 | -$21.61M 10-Q · filed 2026-06-11 | -$31.99M derived: sum of 4 quarters · filed 2026-06-11 | |
| 2026-01-31 | -$7.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-03-16 | -$14.33M 10-Q · filed 2026-03-16 | -$24.71M derived: sum of 3 quarters · filed 2026-03-16 | -$27.90M derived: sum of 4 quarters · filed 2026-06-11 | |
| 2025-10-31 | -$6.81M 10-Q · filed 2025-12-12 | -$17.18M derived: sum of 2 quarters · filed 2025-12-12 | -$20.37M derived: sum of 3 quarters · filed 2026-06-11 | -$22.69M derived: sum of 4 quarters · filed 2026-06-11 | |
| 2025-07-31 | -$10.38M derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | -$13.57M derived: sum of 2 quarters · filed 2026-06-11 | -$15.88M derived: sum of 3 quarters · filed 2026-06-11 | -$18.92M 10-K · filed 2025-10-29 | |
| 2025-04-30 | -$3.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-06-11 | -$5.50M derived: sum of 2 quarters · filed 2026-06-11 | -$8.55M 10-Q · filed 2026-06-11 | -$11.44M derived: sum of 4 quarters · filed 2026-06-11 | |
| 2025-01-31 | -$2.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-03-16 | -$5.36M 10-Q · filed 2026-03-16 | -$8.25M derived: sum of 3 quarters · filed 2026-03-16 | -$8.50M derived: sum of 4 quarters · filed 2026-03-16 | |
| 2024-10-31 | -$3.04M 10-Q · filed 2025-12-12 | -$5.93M derived: sum of 2 quarters · filed 2025-12-12 | -$6.18M derived: sum of 3 quarters · filed 2025-12-12 | -$8.71M derived: sum of 4 quarters · filed 2025-12-12 | |
| 2024-07-31 | -$2.89M derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | -$3.14M derived: sum of 2 quarters · filed 2025-10-29 | -$5.67M derived: sum of 3 quarters · filed 2025-10-29 | -$7.80M 10-K · filed 2025-10-29 | |
| 2024-04-30 | -$251.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-06-11 | -$2.78M derived: sum of 2 quarters · filed 2025-06-11 | -$4.91M 10-Q · filed 2025-06-11 | -$6.36M derived: sum of 4 quarters · filed 2025-06-11 | |
| 2024-01-31 | -$2.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-03-14 | -$4.66M 10-Q · filed 2025-03-14 | -$6.11M derived: sum of 3 quarters · filed 2025-03-14 | -$7.42M derived: sum of 4 quarters · filed 2025-03-14 | |
| 2023-10-31 | -$2.13M 10-Q · filed 2024-12-11 | -$3.58M derived: sum of 2 quarters · filed 2024-12-20 | -$4.89M derived: sum of 3 quarters · filed 2024-12-20 | -$10.44M derived: sum of 4 quarters · filed 2024-12-20 | |
| 2023-07-31 | -$1.45M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-20 | -$2.76M derived: sum of 2 quarters · filed 2024-12-20 | -$8.31M derived: sum of 3 quarters · filed 2024-12-20 | -$10.89M 10-K/A · filed 2024-12-20 | |
| 2023-04-30 | -$1.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-06-14 | -$6.86M derived: sum of 2 quarters · filed 2024-06-14 | -$9.44M 10-Q · filed 2024-06-14 | -$11.34M derived: sum of 4 quarters · filed 2024-06-14 | |
| 2023-01-31 | -$5.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-03-14 | -$8.12M 10-Q · filed 2024-03-14 | -$10.03M derived: sum of 3 quarters · filed 2024-03-14 | -$20.39M derived: sum of 4 quarters · filed 2024-03-14 | |
| 2022-10-31 | -$2.58M 10-Q · filed 2023-12-14 | -$2.55M 10-Q · filed 2022-12-13 | -$4.48M derived: sum of 2 quarters · filed 2023-12-14 | -$14.85M derived: sum of 3 quarters · filed 2023-12-14 | -$22.18M derived: sum of 4 quarters · filed 2023-12-14 |
| 2022-07-31 | -$1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-30 | -$12.27M derived: sum of 2 quarters · filed 2023-10-30 | -$19.61M derived: sum of 3 quarters · filed 2023-10-30 | -$26.08M 10-K · filed 2023-10-30 | |
| 2022-04-30 | -$10.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-06-13 | -$17.70M derived: sum of 2 quarters · filed 2023-06-13 | -$24.18M 10-Q · filed 2023-06-13 | -$31.16M derived: sum of 4 quarters · filed 2023-06-13 | |
| 2022-01-31 | -$7.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-03-14 | -$13.81M 10-Q · filed 2023-03-14 | -$20.79M derived: sum of 3 quarters · filed 2023-03-14 | -$23.89M derived: sum of 4 quarters · filed 2023-03-14 | |
| 2021-10-31 | -$6.47M 10-Q · filed 2022-12-13 | -$13.46M derived: sum of 2 quarters · filed 2022-12-13 | -$16.55M derived: sum of 3 quarters · filed 2022-12-13 | -$19.42M derived: sum of 4 quarters · filed 2022-12-13 | |
| 2021-07-31 | -$6.98M derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-31 | -$10.07M derived: sum of 2 quarters · filed 2022-10-31 | -$12.95M derived: sum of 3 quarters · filed 2022-10-31 | -$15.60M 10-K · filed 2022-10-31 | |
| 2021-04-30 | -$3.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-06-14 | -$5.97M derived: sum of 2 quarters · filed 2022-06-14 | -$8.62M 10-Q · filed 2022-06-14 | -$10.31M derived: sum of 4 quarters · filed 2022-06-14 | |
| 2021-01-31 | -$2.87M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2022-03-17 | -$5.53M 10-Q · filed 2022-03-17 | -$7.22M derived: sum of 3 quarters · filed 2022-03-17 | -$8.29M derived: sum of 4 quarters · filed 2022-03-17 | |
| 2020-10-31 | -$2.65M 10-Q/A · filed 2022-02-28 | -$4.34M derived: sum of 2 quarters · filed 2022-02-28 | -$5.42M derived: sum of 3 quarters · filed 2022-02-28 | -$6.38M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-07-31 | -$1.69M derived: 10-K 12 month − 10-Q 9 month · filed 2021-10-18 | -$2.77M derived: sum of 2 quarters · filed 2021-10-18 | -$3.73M derived: sum of 3 quarters · filed 2021-10-18 | -$4.67M 10-K · filed 2021-10-18 | |
| 2020-04-30 | -$1.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-06-14 | -$2.04M derived: sum of 2 quarters · filed 2021-06-14 | -$2.98M 10-Q · filed 2021-06-14 | -$3.57M derived: sum of 4 quarters · filed 2021-06-14 | |
| 2020-01-31 | -$964.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-03-17 | -$1.90M 10-Q · filed 2021-03-17 | -$2.49M derived: sum of 3 quarters · filed 2021-03-17 | -$4.13M derived: sum of 4 quarters · filed 2021-03-17 | |
| 2019-10-31 | -$936.00K 10-Q · filed 2020-12-15 | -$1.53M derived: sum of 2 quarters · filed 2020-12-15 | -$3.17M derived: sum of 3 quarters · filed 2020-12-15 | -$3.34M derived: sum of 4 quarters · filed 2020-12-15 | |
| 2019-07-31 | -$594.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-29 | -$2.23M derived: sum of 2 quarters · filed 2020-10-29 | -$2.41M derived: sum of 3 quarters · filed 2020-10-29 | -$3.13M 10-K · filed 2020-10-29 | |
| 2019-04-30 | -$1.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-06-09 | -$1.81M derived: sum of 2 quarters · filed 2020-06-09 | -$2.54M 10-Q · filed 2020-06-09 | -$3.28M derived: sum of 4 quarters · filed 2020-06-09 | |
| 2019-01-31 | -$175.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-03-05 | -$899.00K 10-Q · filed 2020-03-05 | -$1.64M derived: sum of 3 quarters · filed 2020-03-05 | -$2.75M derived: sum of 4 quarters · filed 2020-03-05 | |
| 2018-10-31 | -$724.00K 10-Q · filed 2019-12-09 | -$1.47M derived: sum of 2 quarters · filed 2019-12-09 | -$2.58M derived: sum of 3 quarters · filed 2019-12-09 | -$2.51M derived: sum of 4 quarters · filed 2019-12-09 | |
| 2018-07-31 | -$745.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-10-04 | -$1.86M derived: sum of 2 quarters · filed 2019-10-04 | -$1.79M derived: sum of 3 quarters · filed 2019-10-04 | -$1.81M 10-K · filed 2019-10-04 | |
| 2018-04-30 | -$1.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-06-05 | -$1.04M derived: sum of 2 quarters · filed 2019-06-05 | -$1.07M 10-Q · filed 2019-06-05 | -$2.21M derived: sum of 4 quarters · filed 2019-06-05 | |
| 2018-01-31 | $70.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-03-12 | $41.00K 10-Q · filed 2019-03-12 | -$1.10M derived: sum of 3 quarters · filed 2019-03-12 | -$1.21M derived: sum of 4 quarters · filed 2019-03-12 | |
| 2017-10-31 | -$29.00K 10-Q · filed 2018-12-10 | -$1.17M derived: sum of 2 quarters · filed 2018-12-10 | -$1.28M derived: sum of 3 quarters · filed 2018-12-10 | ||
| 2017-07-31 | -$1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-15 | -$1.25M derived: sum of 2 quarters · filed 2018-10-15 | -$1.62M 10-K · filed 2018-10-15 | ||
| 2017-04-30 | -$110.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-06-11 | -$478.00K 10-Q · filed 2018-06-11 | |||
| 2017-01-31 | -$368.00K 10-Q · filed 2018-03-12 | ||||
| 2016-07-31 | $72.00K 10-K · filed 2018-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |